Showing results (201-210 of 1,138) with videos related to
Sort By:
Pageof 114
The Journal of Biological Chemistry|January 3, 2009
Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturaseZheng Zheng Li, Michael Berk, Thomas M McIntyre, et al.Trends in Pharmacological Sciences|February 2, 2013
The promise of N-acetylcysteine in neuropsychiatryMichael Berk, Gin S Malhi, Laura J Gray, et al.Frontiers in Psychiatry|April 17, 2020
Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male RatsJana Lotter, Marisa Möller, Olivia Dean, et al.The Lancet. Psychiatry|June 12, 2025
Lithium as a disease-modifying drug for bipolar disorderRobert M Post, Victor W Li, Michael Berk, et al.Journal of Affective Disorders|February 15, 2026
The role of treatment expectancy in lifestyle interventions for depressionDeborah N Ashtree, Karyn Richardson, Mohammadreza Mohebbi, et al.Addictive Behaviors|July 2, 2013
Clusters of personality traits and psychological symptoms associated with later benzodiazepine prescriptions in the general population: The HUNT Cohort StudyTrond Nordfjærn, Ottar Bjerkeset, Steven Moylan, et al.BMC Medicine|November 29, 2012
Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differencesGjertrud Svendal, Ole Bernt Fasmer, Anders Engeland, et al.Current Pharmaceutical Design|September 9, 2016
Gut Permeability and Microbiota in Parkinson's Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic PathwaysGeorge Anderson, Moonsang Seo, Michael Berk, et al.The Australian and New Zealand Journal of Psychiatry|May 8, 2014
Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollariesJustin Davis, Steven Moylan, Brian H Harvey, et al.CNS Spectrums|August 27, 2015
Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathwaysMarta Martin-Subero, George Anderson, Buranee Kanchanatawan, et al.Pageof 114